Molecular Partners Ag (MOLN) EBIT Margin (2021 - 2025)
Historic EBIT Margin for Molecular Partners Ag (MOLN) over the last 5 years, with Q3 2025 value amounting to 168555835.43%.
- Molecular Partners Ag's EBIT Margin fell 1685536931400.0% to 168555835.43% in Q3 2025 from the same period last year, while for Sep 2025 it was 263599.18%, marking a year-over-year decrease of 2625683100.0%. This contributed to the annual value of 0.0% for FY2024, which is 8728600.0% down from last year.
- According to the latest figures from Q3 2025, Molecular Partners Ag's EBIT Margin is 168555835.43%, which was down 1685536931400.0% from 1431.03% recorded in Q1 2025.
- Over the past 5 years, Molecular Partners Ag's EBIT Margin peaked at 486415.0% during Q4 2021, and registered a low of 168555835.43% during Q3 2025.
- In the last 5 years, Molecular Partners Ag's EBIT Margin had a median value of 600.34% in 2022 and averaged 9338021.62%.
- As far as peak fluctuations go, Molecular Partners Ag's EBIT Margin surged by 27971800bps in 2024, and later tumbled by 2000000000bps in 2025.
- Molecular Partners Ag's EBIT Margin (Quarter) stood at 486415.0% in 2021, then crashed by -100bps to 61.5% in 2022, then crashed by -1307bps to 742.14% in 2023, then surged by 100bps to 0.93% in 2024, then tumbled by 2000000000bps to 168555835.43% in 2025.
- Its EBIT Margin stands at 168555835.43% for Q3 2025, versus 1431.03% for Q1 2025 and 0.93% for Q4 2024.